Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Nutex Health (NUTX) Shares Outstanding (2016 - 2026)

Nutex Health (NUTX) has disclosed Shares Outstanding for 17 consecutive years, with $7.0 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding rose 16.82% year-over-year to $7.0 million; the TTM value through Mar 2026 reached $7.0 million, up 16.82%, while the annual FY2025 figure was $7.1 million, 28.58% up from the prior year.
  • Shares Outstanding hit $7.0 million in Q1 2026 for Nutex Health, down from $7.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $649.8 million in Q3 2022 and bottomed at $4.3 million in Q4 2022.
  • Average Shares Outstanding over 5 years is $115.7 million, with a median of $5.5 million recorded in 2024.
  • Year-over-year, Shares Outstanding tumbled 99.32% in 2023 and then surged 32.39% in 2025.
  • Nutex Health's Shares Outstanding stood at $4.3 million in 2022, then grew by 4.07% to $4.5 million in 2023, then rose by 22.17% to $5.5 million in 2024, then rose by 28.58% to $7.1 million in 2025, then dropped by 1.91% to $7.0 million in 2026.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $7.0 million, $7.1 million, and $6.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.